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Summary
Objective: The objective of this study was to examine expression and regulation of Toll-like receptor 2 (TLR2) in human articular chondrocytes.
Methods: Human articular chondrocytes were enzymatically isolated from normal and osteoarthritic knee cartilage. Immunohistochemistry,
Western blotting, and reverse transcriptase-polymerase chain reaction (RT-PCR) were used to assess the expression of toll-like receptors.
Following stimulation of chondrocytes in vitro by IL-1b and ﬁbronectin proteolytic fragments, the relative levels of mRNA for TLR2 were
determined by quantitative real-time PCR. MyD88 activation and nuclear factor-kB (NF-kB) translocation were evaluated by
immunoprecipitation and electrophoretic mobility shift assay, respectively.
Results: Human articular chondrocytes mainly expressed TLR1, 2, 5 by RT-PCR. Protein expression of TLR2 was also identiﬁed in adult
human articular cartilage. TLR2 was upregulated following IL-1b and ﬁbronectin proteolytic fragments stimulation in primary cultures of
osteoarthritic articular chondrocytes. Fibronectin proteolytic fragments-induced TLR2 upregulation involved an IL-1b autocrine/paracrine
pathway.
Conclusions: TLR2 is expressed in human articular cartilage and is upregulated by proarthritic agents including IL-1b and ﬁbronectin
fragments. Signaling through TLR is a novel pro-inﬂammatory mechanism in osteoarthritis and targeting of these signaling pathways may be of
value in treatment of degenerative joint disease.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Chondrocyte, Toll-like receptor, IL-1b, Fibronectin, Osteoarthritis.
International
Cartilage
Repair
SocietyIntroduction
Toll-like receptors (TLRs) have been established to play an
important role in the activation of innate immunity by
recognizing speciﬁc patterns of microbial components1.
The mammalian homologues of TLRs belong to a family
that currently consists of 10 members in humans2e6. They
are expressed differentially in certain tissues and cell types
and have been proposed to act as pattern recognition
receptors7,8. Pattern recognition receptors are germ line-
encoded receptors involved in the recognition of conserved
microbial constituents9,10. The typical examples are TLR2,
involved in the recognition of various gram-positive bacterial
compounds and leptospiral lipopolysaccharide (LPS), and
TLR4 and TLR9 involved in the innate response to LPS and
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Structurally, the cytoplasmic domains of the TLRs, beside
their structural and functional similarities to Drosophila Toll,
show homologies to the interleukin (IL)-1 receptor in-
tracellular signaling domain (TIR domain)13,14. TLRs there-
fore use similar intracellular signaling molecules including
MyD88, IL-1R-associated protein kinase and tumor necro-
sis factor receptor-activated factor 615,16. TLR signaling is
also associated with activation of nuclear factor (NF)-kB
and mitogen-activated protein kinase resulting in the pro-
duction of mediators of the innate immune system such as
IL-1, IL-6, IL-8, tumor necrosis factor-alpha (TNF-a)17,18.
In the absence of infection, the TLRs may also recognize
endogenous ligands induced during an inﬂammatory re-
sponse and trigger an immune response. The Spatzle
protein, the ﬁrst identiﬁed endogenous ligand for Toll, from
inactive precursors in Drosophila, induces ligand-dependent
toll-like receptor dimerization19,20. Human heat shock pro-
tein 60 released from necrotic, but not apoptotic, cells may
activate TLR4 in macrophages under stress conditions21.
There is also growing evidence that TLR2 gene expression
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such as IL-1a and reactive oxygen species22.
Osteoarthritis (OA) is a complex disease involving both
biomechanical and metabolic factors which alter the tissue
homeostasis of articular cartilage and subchondral
bone23e25. Cartilage breakdown involves both extracellular
matrix degradation and production of metabolically active
breakdown products such as ﬁbronectin fragments26 and
activity of cytokines such as IL-1 and TNF-a produced by
activated synoviocytes, mononuclear cells or by articular
chondrocytes themselves27,28. In view of the recognized
relationship between TLR and inﬂammatory mediators in
other tissues and the potential of these molecules to be
involved in the catabolic response in osteoarthritis we
investigated TLR expression in osteoarthritic chondrocytes
and ascertained whether TLR expression was regulated by
IL-1b and ﬁbronectin fragments.
Materials and methods
CHONDROCYTE ISOLATION AND CULTURE
Human cartilage samples were obtained from knee joints
at total knee replacement (nZ 17, mean age, 68 years;
range 56e78 year). Residual osteoarthritic cartilage with
predominantly grade II and III lesions according to the
system described by Collins/McElligot system was cut and
pooled29,30. A few residual areas of macroscopically normal
cartilage from three donors were also taken. Normal human
cartilage was collected from four patients undergoing leg
surgery after trafﬁc accident injury. The cartilage was cut
into small fragments with a scalpel and incubated in
antimicrobial solution for 1 h at room temperature. Cartilage
fragments were then washed twice with sterile phosphate
buffered saline (PBS) and sequentially enzyme digested at
37(C in 95% air/5% CO2 with 0.25% trypsin (Gibco,
Carlsbad, CA, USA) for 30 min and 3 mg/ml collagenase
(Sigma, St. Louis, MO, USA) for up to 48 h. The samples
were checked for digestion by examination under micro-
scope. The cell suspension was collected using a sterile
pastette and strained through a sterile strainer to remove
undigested cartilage fragments. The cell suspension was
centrifuged at 1000 rpm for 10 min, the supernatant
discarded and the pellet re-suspended in PBS. This was
repeated twice more to give three PBS washes. The cells
were re-suspended in 10 ml Iscove’s modiﬁed Dulbecco’s
medium (Gibco) supplemented with 10% FBS (Sigma),
100 I.U./ml penicillin (Gibco) and 100 mg/ml streptomycin
and then ﬁltered through a 70 mm cell sieve (Falcon, Becton
Dickinson, Franklin Lakes, NJ, USA) to remove large cell
clumps and pieces of debris. Cells were counted using
a haemocytometer and viability checked using trypan blue
dye. Cells were seeded in complete medium at a density of
5! 105 cell/ml in 55 mm petri dishes and cultured in
a humidiﬁed 5% CO2 atmosphere at 37(C.Primary nonconﬂuent, 1e2-week cultures of chondro-
cytes from normal or osteoarthritic articular cartilage were
used in all experiments unless otherwise stated. Morpho-
logically, the cells studied were typically ﬂattened with
a polygonal cell shape and RT-PCR demonstrated expres-
sion of type II collagen and aggrecan mRNA. A minimum of
three donors was used for each experiment.
EXPERIMENTAL PROTOCOL
Dishes of chondrocytes were placed in serum-free media
overnight, then incubated with either 10 ng/ml of IL-1b
(R&D Systems Inc. Minneapolis, MN, USA) at 37(C for
0 (control), 2 and 4 h, 0.5 mg/ml of three types of ﬁbronectin
proteolytic fragments (29, 45, and 70 kDa, respectively)
(Sigma) for 6 h or 10 ng/ml of IL-1ra (R&D) for 30 min.
REVERSE TRANSCRIPTION-POLYMERASE
CHAIN REACTION (RT-PCR)
Total RNA was isolated from cells using TriZOL reagent
(Invitrogen Cor.,Carlsbad, CA, USA). For ﬁrst strand cDNA
synthesis, 3 mg of total RNA was used in a single-round RT
reaction, containing 2.5 mg Oligo(dT)14 primer, 1 mM
dNTPs, 1! ﬁrst strand buffer, 0.4 mM DTT, 80 units
RNaseOut recombinant ribonuclease inhibitor, and
300 units of superscript II reverse transcriptase (Invitrogen).
PCR was run using 0.9 ml of the RT reaction mixture as
template, 0.4 mM of gene speciﬁc primers, 1! PCR buffer,
0.25 mM dNTPs, and 1.5 units of KlenTaq DNA polymerase
(Ab Peptides Inc., St. Louis, MO, USA). The ampliﬁcation
was carried out at 94(C for 2 min, then for 25 cycles at
94(C for 45 s, 55(C for 1 min, and 72(C for 45 s followed
by a ﬁnal extension at 72(C for 10 min. All PCR products
were size-fractionated by a 1% agarose gel electrophoresis,
and DNA bands were visualized by staining the gel with
0.1 mg/ml ethidium bromide. The bands were analyzed
using gel documentation system (Bio-Proﬁl, Bio-1D version
99, Viogene, USA). The values were expressed as ratio of
the target gene to the control glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The primers used are summa-
rized in Table I31. All the primers yielded positive bands by
RT-PCR. PCR products for TLR2 were also puriﬁed and
subjected to automatic sequencing.
REAL-TIME QUANTITATIVE PCR
PCR reaction was performed by using the LightCycler-
FastStart DNA master Sybr Green I (Roche Diagnostics).
For LightCycler reaction, a mastermix of the following
reaction components was prepared to the indicated end
concentration: 13 ml water, 2.4 ml MgCl2 (4 mM), 0.8 ml
forward primer (0.4 mM), 0.8 ml reverse primer (0.4 mM)
and 2.0 ml LightCycler (Fast Start DNA Master SYBR Green
I; Roche Diagnostics). LightCycler mastermix (19 ml) wasTable I
Oligonucleotides primers for semiquantitative RT-PCR analysis
cDNA Forward primers Reverse primers
TLR1 CAGTTTCCCACCCATCAGC TTAAGCTATTAGATCCTTCATG
TLR2 AGTTGATGACTCTACCAGATG GTCAATGATCCACTTGCCAG
TLR3 ACACACTTCCAGCATCTGTC TGCTGTTAACAATTGCTTCTAG
TLR4 CTTATAAGTGTCTGAACTCCC TACCAGCACGACTGCTCAG
TLR5 AAGGTTGTGATGAAGAGGAAG CTGGTACTG GACAAGGAC
GAPDH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC
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added as PCR template. Capillaries were sealed, centri-
fuged and placed into the LightCycler rotor. The following
LightCycler experimental protocol was used: denaturation
program (95(C for 10 min), ampliﬁcation and quantiﬁcation
program repeated 30e40 times (95(C for 15 s, 56(C for
10 s, 72(C for 60 s with a single ﬂuorescence measure-
ment), melting curve program 60e98(C with a heating rate
of 0.1(C/s and a continue ﬂuorescence measurement and
ﬁnally a cooling step to 40(C. Fluorescence was measured
continuously during the slow temperature rise to monitor the
dissociation of the dsDNA. To standardize mRNA levels,
GAPDH served as internal control. Ampliﬁcation products
performed in the LightCycler were also checked by
electrophoresis on 1.5% ethidium bromide stained agarose
gel. The estimated size of the ampliﬁed fragments matched
the calculated size.
PROTEIN EXTRACTION, WESTERN BLOTTING,
AND IMMUNOHISTOCHEMISTRY
Following IL-1b or ﬁbronectin fragments stimulation, cells
were immediately washed with ice-cold PBS containing
100 mM Na3VO4 (Sigma) and lysed in situ with ice-cold lysis
buffer at 4(C for 15 min. Lysis buffer contained 1% Igepal
(Sigma), 100 mM Na3VO4, and protease inhibitor cocktail
tablet (Roche Diagnostics, Mannheim, Germany). Whole
cell lysates were collected after centrifugation at 13,000 rpm
for 15 min. Protein concentration was determined by Lowry
method. Equal amounts of protein (20 mg) were loaded onto
7.5% SDS-polyacrylamide gel and were transferred to
polyvinylidene ﬂuoride (PVDF) membranes (Millipore Im-
mobilon-P, Sigma). Membranes were blocked overnight at
4(C with 2% BSA in TBST (12.5 mM Tris/HCl, pH 7.6,
137 mM NaCl, 0.1% Tween 20). After washing three times
with TBST, blots were incubated for 1 h at room tempera-
ture with anti-TLR2 antibody (Santa Cruz & eBioscience,
CA, USA) diluted in TBST. After washing six times with
TBST, the blots were then incubated with HRP labeled
secondary antibody for 1 h at room temperature. Mem-
branes were rewashed extensively and the binding was
detected using Enhanced Chemiluminescense Western
blotting detection system (Santa Cruz), according to the
manufacturer’s instructions. Mouse monoclonal antibody
tubulin Ab-4 served as internal control (NeoMarkers,
Fremont, CA, USA).
Formalin-ﬁxed, parafﬁn-embedded tissue blocks from
normal and osteoarthritic cartilage were subjected to
immunohistochemistry. Immunodection for TLR2 was per-
formed with a standard avidinebiotineperoxidase complex
detection kit (DakoCytomation, Glostrup, Denmark). Sec-
tions were dewaxed and subjected to heat pre-treatment
with 10 mM citrate buffer (pH 6.0) at 60(C for overnight.
Endogenous peroxidase activity and non-speciﬁc binding
were blocked by incubation with 3% hydrogen peroxide and
non-immune goat serum, respectively. Slides were then
incubated sequentially with primary antibody for 60 min,
biotinylated secondary antibody for 30 min, and peroxidase-
conjugated streptavidin for 30 min. The chromogen
3-amino-9-ethylcarbazole (AEC) was used to localize
positive staining by light microscopy.
ACTIVATION OF MYD88
One ml aliquot of protein at a concentration of 500 mg/ml
was used for phosphotyrosine immunoprecipitation. Mono-
clonal antiphosphotyrosine agarose beads (SigmaImmunochemicals) were incubated with cytoplasmic protein
fraction (see below) at 4(C overnight. The beads were
sedimented by centrifugation at 13,000 rpm for 15 min and
washed twice with ice-cold lysis buffer and once with ice-
cold PBS containing 1 mM Na3VO4. SDS-sample buffer
was added to the agarose beads and then boiled for 5 min
to dissociate the proteins. Equivalent amounts of immuno-
precipitated proteins were separated on a 7.5% SDS-PAGE
under reducing conditions. Western blotting and immuno-
detection was carried out using the anti-MyD88 antibody
(ProSci Inc., Poway, CA, USA).
ACTIVATION OF NF-kB BY EMSA
Chondrocytes were incubated with 10 ng/ml of IL-1b at
37(C for 0, 2, and 4 h and 0.5 mg/ml of the 45 kDa
ﬁbronectin proteolytic fragment for 0 and 6 h. Nuclear and
cytoplasmic extracts were prepared using NE-PER nuclear
and cytoplasmic extraction reagents (Pierce, Rockford, IL,
USA). Nuclear protein concentrations were determined
using the BCA Protein Assay Reagent kit (Pierce). Non-
radioactive electrophoretic mobility shift assay (EMSA) was
performed using an EMSA kit according to the manufactur-
er’s instructions (Panomics, Inc., Redwood City, CA, USA).
Six micrograms of nuclear protein was used to bind
biotinylated oligonucleotides containing the NF-kB-binding
site for 30 min at room temperature. The samples were
separated in a nondenaturing polyacrylamide gel (6%, with
2.5% glycerol) and blotted on a Biodyne B (0.45 mm)
positively charged nylon membrane (Pall Schweiz AG,
Basel, Switzerland). The biotin was labeled with alkaline
phosphatase-conjugated streptavidin and alkaline phos-
phatase was detected with Enhanced Chemiluminescense
detection system (Santa Cruz).
STATISTICAL ANALYSIS
Quantiﬁcation data of TLR2 mRNA expression levels was
collected from Roche LightCycler PCR reaction as de-
scribed above. One-way analysis of variance (ANOVA) was
used to compare the relative expression levels of TLR2
gene normalized with GAPDH among various treated
chondrocyte groups.
Results
TLRS EXPRESSION IN HUMAN ARTICULAR CHONDROCYTES
TLR1e5 gene expression in human articular chondro-
cytes from both normal and OA cartilage was examined by
RT-PCR. In both normal and OA chondrocytes TLR1, 2,
and 5, but not TLR3 or 4 were expressed (Fig. 1). Basal
Fig. 1. Toll-like receptor (TLR) 1e5 gene expression on (A) normal
articular chondrocytes and (B) chrondrocytes from osteoarthritic
cartilage by RT-PCR.
882 S.-L. Su et al.: TLR2 in chondrocytesFig. 2. Expression of TLR2 in adult human articular cartilage. Normal (A) and osteoarthritic (B) human articular cartilage immunostained with
antibody against TLR2. Very weak immunoreactivity was observed in normal chondrocytes, but positive immunoreactivity in the large majority
of OA chondrocytes (original magniﬁcation !400).expression level varied from patient to patient; however,
TLR2 gene expression appeared greater in chondrocytes
from osteoarthritic cartilage when compared to chondro-
cytes from normal cartilage. By quantitative PCR, TLR2
levels from osteoarthritic chondrocytes (nZ 8) compared to
normal chondrocytes (nZ 4) showed 5.4G 3.6-fold in-
crease (P! 0.05). The PCR products from normal and
OA cells were subjected to automatic sequence which
demonstrated 100% homology to the designed sequence
(Gene Bank BC033756). Immunohistochemistry showed
stronger expression of TLR2 by chondrocytes of OA
cartilage in comparison to chondrocytes in normal cartilage
(Fig. 2).
TLR2 mRNA EXPRESSION BY IL-1b AND FIBRONECTIN
FRAGMENTS
As the RT-PCR analysis suggested that TLR2 gene
expression was upregulated in OA chondrocytes studies
were undertaken to ascertain whether catabolic factors
implicated in OA could regulate TLR gene expression.
Primary cultures of OA chondrocytes were incubated with
10 ng/ml IL-1b for 0, 2, and 4 h. TLR2 showed signiﬁcant
upregulation which was time dependent. There was no
change in levels of TLR1, 3, 4, and 5 (Fig. 3). Real-time RT-
PCR was performed to quantify IL-1b effect on TLR2 gene
expression. As expected, IL-1b induced a marked increase
of TLR2 mRNA levels which was time dependent, in-
creasing over the 4 h incubation period (P! 0.05) (Fig. 4).
Following 2 h stimulation with IL-1b a 6.2G 3.2-fold in-
crease over levels in unstimulated controls was seen. This
increased to a 36.7G 14.2-fold increase at 4 h.
Primary cultures of OA chondrocytes were also incubated
with 29, 45, and 70 kDa ﬁbronectin proteolytic fragments at
37(C for 6 h to characterize effects on TLR2 gene
expression. RT-PCR showed TLR2 upregulation to be
induced by each of the three ﬁbronectin fragments, with the
45 kDa ﬁbronectin fragment having the greatest effect
[Fig. 5(A)].As ﬁbronectin fragments have been shown to induce
production of IL-1b in human articular chondrocytes32 we
assessed potential roles for IL-1b in ﬁbronectin fragment
induction of TLR2 gene expression by undertaking experi-
ments in the presence of IL-1ra. The results [Fig. 5(B and
C)] demonstrated that the increase of TLR2 gene expres-
sion following stimulation by the 45 kDa ﬁbronectin frag-
ment was signiﬁcantly inhibited in the presence of IL-1ra.
Fig. 3. Gene expression of TLR induced by IL-1b stimulation. OA
chondrocytes were incubated with IL-1b for 0, 2 or 4 h and
subjected to total RNA isolation and RT-PCR. TLR2 was
signiﬁcantly upregulated following IL-1b stimulation for 2 and 4 h.
GAPDH served as internal control.
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We next studied whether IL-1b actually increased TLR2
expression at the protein level in primary cultured OA
chondrocytes. Chondrocytes were treated with IL-1b at
37(C for 0, 12, and 24 h. Total protein was extracted and
analyzed by Western blot analysis (Fig. 6). Levels of TLR2
protein were elevated following 12 and 24 h incubation with
IL-1b.
MYD88 AND NF-kB ACTIVATION BY 45 kDa FIBRONECTIN
FRAGMENT AND IL-1b
As activation of IL-1 receptor by IL-1 results in the
recruitment of MyD88 and IL-1 receptor-associated kinase
(IRAK) complex to the receptor33 we investigated whether
the 45 kDa ﬁbronectin fragment activated a similar signaling
Fig. 4. Effect of IL-1b on the TLR2 mRNA levels by OA primary
chondrocytes. Total RNA was isolated and TLR2 mRNA was
quantiﬁed by real-time RT-PCR as described in Materials and
methods. Increased levels of TLR2 mRNA were demonstrated.
Results were the meanG S.D. of ﬁve experiments performed with
primary chondrocytes of different donors. Comparison of mean
values was performed by ANOVA analysis (*P! 0.05).cascade in human chondrocytes that might be involved in
TLR upregulation. Following incubation with 10 ng/ml IL-1b
for 2e4 h or 0.5 mg/ml 45 kDa ﬁbronectin fragment for 6 h
increase tyrosine phosphorylation of MyD88 was seen
(Fig. 7). Similarly, over the same time period NF-kB
activation was conﬁrmed by EMSA (Fig. 8).
Discussions
The present study has demonstrated that Toll-like
receptors, TLR1, TLR2 and TLR5 are expressed in human
articular chondrocytes, with greater expression of TLR2 in
osteoarthritic chondrocytes and cartilage. TLR2 expression
in primary OA chondrocytes is upregulated by IL-1b and
ﬁbronectin fragments. Fibronectin fragment effects on TLR2
expression appear, at least in part, to be mediated through
IL-1ra suggesting autocrine/paracrine IL-1 activity.
Toll-like receptors have been shown to be involved in
synovial inﬂammation in inﬂammatory joint disease in-
cluding rheumatoid arthritis34, Lyme arthritis35, and strepto-
coccal cell wall-induced arthritis36. Synovium and pannus
from rheumatoid arthritis joints express TLR2 at sites of
attachment and invasion into cartilage and bone34. TLR2
gene was upregulated in both chondrocyte and synoviocyte
cultures by Borrelia burgdorferi, but not by lipopolysaccha-
ride. TLR4 expression, however, was low to undetectable
level, as determined by RT-PCR, and not augmented by the
addition of B. burgdorferi, lipopolysaccharide, and TNF-a35.
TLR2 signaling is important for onset of streptococcal cell
wall-induced arthritis, with TLR2-deﬁcient mice being un-
able to develop either joint swelling or inhibition of cartilage
matrix synthesis following intraarticular injection of strepto-
coccal cell wall36. Consistent with these studies, our data
showed that TLR2 is expressed by chondrocytes and TLR4
in undetectable level by RT-PCR and raise the possibility
that TLR2 may play a role in regulation of cartilage matrix
metabolism.
Pro-inﬂammatory cytokines such as IL-1 and TNF-a pro-
duced by activated synoviocytes, inﬂammatory cells or by
articular chondrocytes play a pivotal role in the initiation and
development of osteoarthritis27,37,38. Matrix breakdown,Fig. 5. Effects of IL-1b, IL-1ra, and ﬁbronectin fragments on the TLR2 gene expression. (A) TLR2 was upregulated by IL-1b and ﬁbronectin
(FN) 45, 29, and 70 kDa fragments. Fibronectin 45 kDa had the highest effect among the three fragments. (B) IL-1ra signiﬁcantly inhibited the
ﬁbronectin-induced TLR2 gene upregulation. IL-1ra itself showed no effect on TLR2 gene expression. (C) The quantitative data is in triplicate
for ﬁbronectin 45 kDa and IL-1ra.
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production of ﬁbronectin proteolytic fragments39. These
fragments have a number of proarthritic effects, including
increasing production of inﬂammatory cytokines and pro-
teases, which further accelerate cartilage damage40e43.
The present study shows that ﬁbronectin fragments in-
crease TLR2 through an IL-1b dependent mechanism.
Interestingly the speciﬁc induction of MMP-9 by monocytic
cells through TLR2 has been shown recently, indicating
possible direct effects of TLR on MMP production by
chondrocytes44.
TLR2 has a broad speciﬁcity for the recognition of
microbial pathogens. It is responsible for the recognition
of Gram-positive bacteria45,46, mycobacterial species47,48,
bacterial lipoproteins49,50, and lipoteichoic acid51. Endoge-
nous ligands for TLR2 are less characterized, although
molecules such as heat shock protein and cellular
ﬁbronectin type III repeat EDA domain for TLR4 have been
identiﬁed as ligands21,52. This prompted us to test the effect
of ﬁbronectin fragments on TLR2 regulation. Fibronectin
fragments have been found in human osteoarthritic synovial
ﬂuid53. Fibronectin fragments bind to and penetrate
cartilage tissue resulting in proteinase expression and
cartilage damage54. The 29 kDa ﬁbronectin fragment shows
the most potent chondrolytic activity among speciﬁc pro-
teolytic fragments of ﬁbronectin42. These fragments in-
crease the levels of TNF-a, IL-1b, and IL-1a in cultured
human articular cartilage32. They also elevate matrix
metalloproteinase production, enhance rates of proteogly-
can loss, and suppress proteoglycan synthesis26,42,55,56.
The pathophysiological signiﬁcance of the action of these
fragments has been demonstrated by in vivo studies where
Fig. 6. Western blot analysis of TLR2 in human articular
chondrocytes. Cells were cultured for 12 and 24 h in the presence
of IL-1b (10 ng/ml). The cells were lysed and protein extracts were
analyzed by Western blot with a speciﬁc antibody for TLR2. Protein
levels increased after IL-1b stimulation. Tubulin served as internal
control.
Fig. 7. Survey of MyD88 activation. OA primary chondrocytes were
incubated with (A) IL-1b for 0, 2, 4 h or (B) 45 kDa ﬁbronectin
fragment for 0, 6 h. Cells were lysed and protein extracts were
subjected to immunoprecipitation with tyrosine phosphorylation and
immunodetection with MyD88. Increased tyrosine phosphorylation
of MyD88 (p-MyD88) was identiﬁed.injection of the 29 kDa ﬁbronectin fragments into rabbit
knee joints caused depletion of cartilage proteoglycan57.
The 45 kDa ﬁbronectin fragment has been shown to induce
MMP-3 and 13 synthesis, via an IL-1-independent mecha-
nism, and aggrecanase-mediated aggrecan degradation58.
Three ﬁbronectin fragments were used in the present study
including the 29 kDa heparin binding fragment59 (type I
repeating units), the 45 kDa gelatin binding fragment60
(consisting of type I and type II repeating units), and the
70 kDa heparin and gelatin binding fragment61. All three
fragments, in a similar fashion to IL-1b induced TLR2
upregulation although the 45 kDa fragment appeared to
have the greatest effect. Inhibition of this upregulation of
TLR2 gene expression by IL-1ra would be consistent with
activation of an IL-1 autocrine/paracrine loop.
Several studies have reported that upregulation of TLR2
mRNA in response IL-1a and TNF-a in hepatocytes is the
result of transcriptional activation of the TLR2 gene in which
NF-kB activation is essential62. IL-1b greatly up regulates
TLR2 expression in human epithelial cells via IKKb-IkBa-
dependent NF-kB pathway63. As both MyD88 activation
and NF-kB translocation are seen following treatment of
chondrocytes with IL-1b and ﬁbronectin fragment it is
possible that these molecules are involved in the regulation
of TLR transcription; however, further studies are required
to investigate this possibility and to establish whether these
might be new potential targets for pharmacological in-
tervention in the treatment of osteoarthritis.
In summary, we have demonstrated that TLR2 is
expressed in human articular cartilage and is upregulated
by IL-1b and ﬁbronectin proteolytic fragments. We provide
evidence that supports the idea that TLR2 upregulation by
ﬁbronectin fragment involves an IL-1 autocrine/paracrine
loop. The results show for the ﬁrst time that TLR2
expression in chondrocytes may be upregulated by a non-
infectious, inﬂammatory pathway and raise the possibility
that this family of molecules, of recognized importance in
a range of inﬂammatory conditions, may signiﬁcantly
contribute to the detrimental inﬂammatory/catabolic activi-
ties of chondrocytes in osteoarthritis.
Fig. 8. Electrophoresis mobility shift assay with NF-kB-binding site.
Gel mobility shift assay was performed using a DIG-labeled
synthetic oligonucleotides and nuclear extract from OA chondro-
cytes primary culture with (A) IL-1b stimulation for 0, 2, 4 h or (B)
45 kDa ﬁbronectin fragment for 0, 6 h. The competition assay used
the same unlabeled oligonucleotide sequence with 10! concen-
tration (A. left three lanes 0, 2, 4; B. left two lanes 0, 6). The arrows
indicated the complex of NF-kB and the DIG-labeled oligonucleo-
tides. NF-kB translocation was identiﬁed in OA chondrocyte
incubation with IL-1b at 4 h and 45 kDa ﬁbronectin fragment at
6 h. C lane was free of oligonucleotides.
885Osteoarthritis and Cartilage Vol. 13, No. 10Acknowledgements
This study was supported by a grant from the National
Science Council and National Defense Medical Center, Tri-
Service General Hospital, Taiwan (NSC92-2320-B-016-
033, DOD93-4-02, & TSGH-C93-29).
References
1. Takeda K, Akira S. TLR signaling pathways. Semin
Immunol 2004;16:3e9.
2. Barton GM, Medzhitov R. Control of adaptive immune
responses by toll-like receptors. Curr Opin Immunol
2002;14:380e3.
3. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert
DJ, Jenkins NA, et al. TLR6: a novel member of an
expanding toll-like receptor family. Gene 1999;231:
59e65.
4. Du X, Poltorak A, Wei Y, Beutler B. Three novel
mammalian toll-like receptors: gene structure, expres-
sion, and evolution. Eur Cytokine Netw 2000;11:
362e71.
5. Janeway CA, Medzhitov R. Innate immune recognition.
Annu Rev Immunol 2002;20:197e216.
6. Chuang TH, Ulevitch RJ. Identiﬁcation of hTLR10:
a novel human toll-like receptor preferentially ex-
pressed in immune cells. Biochim Biophs Acta 2001;
1518:157e61.
7. Zhang DA. Toll-like receptor that prevents infection by
uropathogenic bacteria. Science 2004;303:1522e6.
8. Muzio M, Bosisio D, Polentarutti N, D’amico G,
Stoppacciaro A, Mancinelli R, et al. Differential
expression and regulation of toll-like receptors (TLR)
in human leukocytes: selective expression of TLR3 in
dendritic cells. J Immunol 2000;164:5998e6004.
9. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med
2002;30(Suppl):1e11.
10. Underhill DM, Ozinsky A. Toll-like receptors: key
mediators of microbe detection. Curr Opin Immunol
2002;14:103e10.
11. Iwaki D, Mitsuzawa H, Murakami S, Sano H, Konishi M,
Akino T, et al. The extracellular toll-like receptor 2
domain directly binds peptidoglycan derived from
Staphylococcus aureus. J Biol Chem 2002;277:
24315e20.
12. Werts C, Tapping RI, Mathison JC, Chuang TH,
Kravchenko V, Saint GI, et al. Leptospiral lipopolysac-
charide activates cells through a TLR2-dependent
mechanism. Nat Immunol 2001;2:346e52.
13. Rock FL, Hardiman G, Timans JC, Kastelein RA,
Bazan JF. A family of human receptors structurally
releated to Drosophila toll. Proc Natl Acade Sci U S A
1998;95:588e93.
14. Aderem A, Ulevitch RJ. Toll-like receptors in the
induction of the innate immune response. Nature
2000;406:782e7.
15. Heldwein KA, Golenbock DT, Fenton MJ. Recent
advances in the biology of toll-like receptors. Mod
Asp Immunobiol 2001;1:249e52.
16. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S,
Snajo H, et al. A Toll-like receptor recognize s
bacterial DNA. Nature 2000;408:740e5.
17. Takeuchi O, Hoshino K, Akira S. TLR2-deﬁcient
and MyD88-deﬁcient mice are highly susceptible toStaphylococcus aureus infection. J Immunol 2000;
165:5392e6.
18. Chow JC, Young DW, Golenbock DT, Christ WJ,
Gusovsky F. Toll-like receptor-4 mediates lipopoly-
saccharide-induced signal transduction. J Biol Chem
1999;274:10689e92.
19. Levashina EA, Langley E, Green C, Gubb D,
Ashburner D, Hoffmann JH, et al. Constitutive activa-
tion of toll-mediated antifungal defense in serpin-
deﬁcient drosophila. Science 1999;5435:1917e9.
20. Matzinger P. An innate sense of danger. Semin
Immunol 1998;10:399e415.
21. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge:
heat shock protein 60 is a putative endogenous ligand
of the toll-like receptor-4 complex. J Immunol 2000;
164:558e61.
22. Wang T, Lafuse WP, Zwilling BS. Regulation of toll-like
receptor 2 expression by macrophages following
Mycobacterium avium infection. J Immunol 2000;165:
6308e13.
23. Salter DM, Millward-Sadler SJ, Nuki G, Wright MO.
Differential responses of chondrocytes from normal
and osteoarthritic human articular cartilage to me-
chanical stimulation. Biorheology 2002;39:97e108.
24. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine
expression in synovial membranes of patients with
rheumatoid arthritis and osteoarthritis. Ann Rheum Dis
1993;52:870e5.
25. Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-
Pelletier J. Synovial membrane histology and immu-
nopathology in rheumatoid arthritis and osteoarthritis.
In vivo effects of antirheumatic drugs. Arthritis Rheum
1991;34:153e63.
26. Dang Y, Cole AA, Homandberg GA. Comparison of the
catabolic effects of ﬁbronectin fragments in human
knee and ankle cartilages. Osteoarthritis Cartilage
2003;11:538e47.
27. Fernandes JC, Pelletier JM, Pelletier JP. The role of
cytokines in osteoarthritis pathophysiology. Biorheol-
ogy 2002;39:237e46.
28. van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, van
den Berg WB. Role of interleukin-1, tumor necrosis
factor alpha, and interleukin-6 in cartilage proteogly-
can metabolism and destruction. Effect of in situ
blocking in murine antigen- and zymosan-induced
arthritis. Arthritis Rheum 1995;38:164e72.
29. Lee HS, Millward-Sadler SJ, Wright MO, Nuki G,
Salter DM. Integrin and mechanosensitive ion channel-
dependent tyrosine phosphorylation of focal adhesion
proteins and b-catenin in human articular chondro-
cytes after mechanical stimulation. J Bone Miner Res
2000;15:1501e9.
30. Lee HS, Millward-Sadler SJ, Wright MO, Nuki G, Jamal
AI, Salter DM. Activation of integrindRACK1/PKC
signalling in human articular chondrocyte mechano-
transduction. Osteoarthritis Cartilage 2002;10:890e7.
31. Hausmann M, Kiessling S, Mestermann S, Webb G,
Spottl T, Andus T, et al. Toll-like receptors 2 and 4 are
up-regulated during intestinal inﬂammation. Gastroen-
terology 2002;122:1987e2000.
32. Homandberg GA, Hui F. Association of proteoglycan
degradation with catabolic cytokine and stromelysin
release from cartilage cultured with ﬁbronectin frag-
ments. Arch Biochem Biophys 1996;334:325e31.
33. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family
member IRAK-2 and MyD88 as proximal mediators of
IL-1 signaling. Science 1997;278:1612e5.
886 S.-L. Su et al.: TLR2 in chondrocytes34. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE,
Saurenmann T, et al. Expression and regulation of toll-
like receptor 2 in rheumatoid arthritis synovium. Am J
Pathol 2003;162:1221e7.
35. Lin B, Kidder JM, Noring R, Steere AC, Klempner MS,
Hu LT. Differences in synovial ﬂuid levels of matrix
metalloproteinases suggest separate mechanisms of
pathogenesis in Lyme arthritis before and after
antibiotic treatment. J Infect Dis 2001;184:174e80.
36. Joosten LA, Koenders MI, Smeets RL, Heuvelmans-
Jacobs M, Helsen MM, Takeda K, et al. Toll-like
receptor 2 pathway drives streptococcal cell wall-
induced joint inﬂammation: critical role of myeloid
differentiation factor 88. J Immunol 2003;171:
6145e53.
37. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G,
Mineau F, Geng C, et al. Chondroprotective effect of
intraarticular injections of interleukin-1 receptor antag-
onist in experimental osteoarthritis. Suppression of
collagenase-1 expression. Arthritis Rheum 1996;39:
1535e44.
38. Plows D, Probert L, Georgopoulos S, Alexopoulou L,
Kollias G. The role of tumor necrosis factor (TNF) in
arthritis: studies in transgenic mice. Rheumatol Eur
1995; (Suppl 2):51e4.
39. Homandberg GA, Wen C, Hui F. Cartilage damaging
activities of ﬁbronectin fragments derived from carti-
lage and synovial ﬂuid. Osteoarthritis Cartilage 1998;
6:231e44.
40. Heather S, Linh UNG, Amanda JF. The 45 kDa
collagen-binding fragment of ﬁbronectin induces ma-
trix metalloproteinase-13 synthesis by chondrocytes
and aggrecan degradation by aggrecanases. Biochem
J 2002;364:181e90.
41. Arner EC, Tortorella MD. Signal transduction through
chondrocyte integrin receptors induces matrix metal-
loproteinase synthesis and synergizes with interleukin-1.
Arthritis Rheum 1995;38:1304e14.
42. Homandberg GA, Meyers R, Xie DL. Fibronectin
fragments cause chondrolysis of bovine articular
cartilage slices in culture. J Biol Chem 1992;267:
3597e604.
43. Bewsey KE, Wen C, Purple C, Homandberg GA.
Fibronectin fragments induce the expression of
stromelysin-1 mRNA and protein in bovine chondro-
cytes in monolayer culture. Biochim Biophys Acta
1996;1317:55e64.
44. Gebbia JA, Coleman JL, Benach JL. Selective in-
duction of matrix metalloproteinases by Borrelia
burgdorferi via toll-like receptor 2 in monocytes.
J Infect Dis 2004;189:113e9.
45. Yoshimura A, Lien E, Ingalls RR, Tuomanen E,
Dziarski R, Golenbock D. Cutting edge: recognition
of gram-positive bacterial cell wall components by the
innate immune system occurs via toll-like receptor 2.
J Immunol 1999;163:1e5.
46. Schwandner R, Dziarski R, Wesche H, Rothe M,
Kirschning CJ. Peptidoglycan and lipoteichoic acid-
induced cell activation is mediated by toll-like receptor
2. J Biol Chem 1999;274:17406e9.
47. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like
receptor-2 mediates mycobacteria-induced proinﬂam-
matory signaling in macrophages. Proc Natl Acad Sci
U S A 1999;96:14459e63.
48. Means TK, Lien E, Yoshimura A, Wang S, Golenbock
DT, Fenton MJ. The CD14 ligands lipoarabinomannanand lipopolysaccharide differ in their requirement for
toll-like receptors. J Immunol 1999;163:6748e55.
49. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G,
Finberg RW, et al. Toll-like receptor 2 functions as
a pattern recognition receptor for diverse bacterial
products. J Biol Chem 1999;274:33419e25.
50. Brightbill HD, Libraty DH, Krutzik SR, Yang RB,
Belisle JT, Bleharski JR, et al. Host defense mecha-
nisms triggered by microbial lipoproteins through
toll-like receptors. Science 1999;285:732e6.
51. Lehner MD, Morath S, Michelsen KS, Schumann RR,
Hartung T. Induction of cross-tolerance by lipopoly-
saccharide and highly puriﬁed lipoteichoic acid via
different Toll-like receptors independent of paracrine
mediators. J Immunol 2001;166:5161e7.
52. Okamura Y, Watari M, Jerud ES, Young DW,
Ishizaka ST, Rose J, et al. The extra domain A of
ﬁbronectin activates toll-like receptor 4. J Biol Chem
2001;276:10229e33.
53. Xie DL, Meyers R, Homandberg GA. Fibronectin
fragments in osteoarthritic synovial ﬂuid. J Rheumatol
1992;19:1448e52.
54. Xie D, Homandberg GA. Fibronectin fragments bind to
and penetrate cartilage tissue resulting in proteinase
expression and cartilage damage. Biochim Biophys
Acta 1993;1182:189e96.
55. Homandberg GA, Hui F, Wen C, Purple C, Bewsey K,
Koepp H, et al. Fibronectin-fragment-induced cartilage
chondrolysis is associated with release of catabolic
cytokines. Biochem J 1997;321:751e7.
56. Yasuda T, Poole A. A ﬁbronectin fragment induces type
II collagen degradation by collagenase through an
interleukin-1-mediated pathway. Arthritis Rheum 2002;
46:138e48.
57. Homandberg GA, Meyers R, Williams JM. Intraarticular
injection of ﬁbronectin fragments causes severe
depletion of cartilage proteoglycans in vivo. J Rheu-
matol 1993;20:1378e82.
58. Stanton H, Ung L, Fosang AJ. The 45 kDa collagen-
binding fragment of ﬁbronectin induces matrix metal-
loproteinase-13 synthesis by chondrocytes and
aggrecan degradation by aggrecanases. Biochem J
2002;364(Pt 1):181e90.
59. Huff S, Matsuka YV, McGavin MJ, Ingham KC.
Interaction of N-terminal fragments of ﬁbronectin with
synthetic and recombinant D motifs from its binding
protein on Staphylococcus aureus studied using
ﬂuorescence anisotropy. J Biol Chem 1994;269:
15563e70.
60. Penn C, Klotz SA. Binding of plasma ﬁbronectin to
Candida albicans occurs through the cell binding
domain. Microb Pathog 1994;17:387e93.
61. Pickford AR, Potts JR, Bright JR, Phan I, Campbell ID.
Solution structure of a type 2 module from ﬁbronectin:
implications for the structure and function of the
gelatin-binding domain. Structure 1997;5:359e70.
62. Matsumura T, Degawa T, Takii T, Hayashi H, Okamoto
T, Inoue J, et al. TRAF6-NF-kappaB pathway is
essential for interleukin-1-induced TLR2 expression
and its functional response to TLR2 ligand in murine
hepatocytes. Immunology 2003;109:127e36.
63. Sakai A, Han J, Cato ACB, Akira S, Dong Li JD.
Glucocorticoids synergize with IL-1b to induce TLR2
expression via MAP Kinase Phosphatase-1-depen-
dent dual inhibition of MAPK JNK and p38 in epithelial
cells. BMC Mol Biol 2004;5:2.
